Settlements totalling more than €4.5m were approved by the High Court in three cases over the administering for the swine flu jab which caused sleep disorder.
The cases involve two under-18 year olds and an adult man. Nothing can be reported to identify them by order of the court.
The cases were against the Minister for Health, the HSE, and Glaxosmithkline Biologicals SA (GSK) — the producer of swine flu vaccine Pandemrix.
GSK was previously given an indemnity by the State concerning any adverse reactions to the vaccine.
It was claimed in all three cases that the plaintiffs developed narcolepsy.
These settlements arose out of general terms agreed in groundbreaking settlement last year which paved the way for the resolution of 80 cases over the Pandemrix vaccine.
In the first case, Ms Justice Miriam O’Regan approved a settlement of €1m for a teenage boy who received Pandremix when he was six and subsequently developed moderate to severe narcolepsy.
In the second case of another teenage boy, the judge approved a settlement of €1.75m after his counsel Jomathan Kilfeather SC said there was a complicating factor in this case because the child had also been diagnosed with autism which meant that his life in the future will be very different.
In the third case, Ms Justice O’Regan approved a €1.8m settlement for a man in his 20s who received the vaccine in 2009.
He was also diagnosed as suffering from a mental disorder when doing his Junior Certificate which meant he required continuing support and was unlikely to get employment.
